Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Rotella

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Discovery|October 2, 2013
The discovery and development of boceprevirDavid P Rotella
ACS Medicinal Chemistry Letters|June 6, 2014
Drug discovery 2012 and beyondDavid P Rotella
Current Opinion in Investigational Drugs (London, England : 2000)|March 11, 2003
Tadalafil Lilly ICOSDavid P Rotella
Idrugs : the Investigational Drugs Journal|May 22, 2004
American Chemical Society--227th Annual Meeting. NMDA receptor. 28 March - 1 April 2004, Anaheim, CA, USADavid P Rotella
Idrugs : the Investigational Drugs Journal|October 13, 2004
American Chemical Society--228th National Meeting. Technical achievements in organic synthesis. 22-26 August 2004, Philadelphia, PA, USADavid P Rotella
Idrugs : the Investigational Drugs Journal|May 6, 2006
American Chemical Society--231st National Meeting. G-protein-coupled receptor structure, modeling and ligand designDavid P Rotella
Idrugs : the Investigational Drugs Journal|May 6, 2006
American Chemical Society--231st National Meeting. Virtual screening using structure-based and ligand-based methods for lead identificationDavid P Rotella
Idrugs : the Investigational Drugs Journal|October 29, 2005
American Chemical Society--230th National Meeting. Proteins, peptides, amino acids and enzyme inhibitorsDavid P Rotella
ACS Medicinal Chemistry Letters|June 6, 2014
Substituted Benzylspiroindolin-2-one Analogues as Positive Allosteric Modulators of the Muscarinic Acetylcholine Receptor M1David P Rotella
Idrugs : the Investigational Drugs Journal|November 7, 2008
Medicinal Chemistry - XXth International Symposium. Natural products and neurodegenerative diseasesDavid P Rotella
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Discovery|October 2, 2013
The discovery and development of boceprevirDavid P Rotella
ACS Medicinal Chemistry Letters|June 6, 2014
Drug discovery 2012 and beyondDavid P Rotella
Current Opinion in Investigational Drugs (London, England : 2000)|March 11, 2003
Tadalafil Lilly ICOSDavid P Rotella
Idrugs : the Investigational Drugs Journal|May 22, 2004
American Chemical Society--227th Annual Meeting. NMDA receptor. 28 March - 1 April 2004, Anaheim, CA, USADavid P Rotella
Idrugs : the Investigational Drugs Journal|October 13, 2004
American Chemical Society--228th National Meeting. Technical achievements in organic synthesis. 22-26 August 2004, Philadelphia, PA, USADavid P Rotella
Idrugs : the Investigational Drugs Journal|May 6, 2006
American Chemical Society--231st National Meeting. G-protein-coupled receptor structure, modeling and ligand designDavid P Rotella
Idrugs : the Investigational Drugs Journal|May 6, 2006
American Chemical Society--231st National Meeting. Virtual screening using structure-based and ligand-based methods for lead identificationDavid P Rotella
Idrugs : the Investigational Drugs Journal|October 29, 2005
American Chemical Society--230th National Meeting. Proteins, peptides, amino acids and enzyme inhibitorsDavid P Rotella
ACS Medicinal Chemistry Letters|June 6, 2014
Substituted Benzylspiroindolin-2-one Analogues as Positive Allosteric Modulators of the Muscarinic Acetylcholine Receptor M1David P Rotella
Idrugs : the Investigational Drugs Journal|November 7, 2008
Medicinal Chemistry - XXth International Symposium. Natural products and neurodegenerative diseasesDavid P Rotella
Pageof 6